{"id":"https://openalex.org/W4200260910","doi":"https://doi.org/10.1093/ofid/ofab466.016","title":"16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees","display_name":"16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees","alternate_titles":[],"publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W4200260910","doi":"https://doi.org/10.1093/ofid/ofab466.016","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8644892"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofab466.016","doi":"https://doi.org/10.1093/ofid/ofab466.016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.016","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200260910"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofab466.016","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059727205","display_name":"Holly Yu","orcid":"https://orcid.org/0000-0001-8625-4201","observed_orcids":["https://orcid.org/0000-0001-8625-4201"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Yu","raw_affiliation_strings":["Heath Economics and Outcomes Research, Pfizer, Inc. Collegeville PA, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heath Economics and Outcomes Research, Pfizer, Inc. Collegeville PA, Collegeville, PA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040702988","display_name":"Jennifer L. Nguyen","orcid":"https://orcid.org/0000-0002-4064-0227","observed_orcids":["https://orcid.org/0000-0002-4064-0227"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer L Nguyen","raw_affiliation_strings":["Pfizer Inc., New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112423790","display_name":"Tamuno Alfred","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tamuno Alfred","raw_affiliation_strings":["Pfizer Inc., New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102783444","display_name":"Jingying Zhou","orcid":"https://orcid.org/0000-0002-5473-761X","observed_orcids":["https://orcid.org/0000-0002-5473-761X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jingying Zhou","raw_affiliation_strings":["Statistical Programming, Pfizer, Inc. New York NY, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Programming, Pfizer, Inc. New York NY, New York, NY","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033690676","display_name":"Margaret A A Olsen","orcid":"https://orcid.org/0000-0001-7070-9320","observed_orcids":["https://orcid.org/0000-0001-7070-9320"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret A Olsen","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, Missouri","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3465,"currency":"USD","value_usd":3465},"apc_paid":{"value":3465,"currency":"USD","value_usd":3465},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"Supplement_1","first_page":"S11","last_page":"S12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9950000047683716},{"id":"https://openalex.org/keywords/attributable-mortality","display_name":"attributable mortality","score":0.8309999704360962},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9900000095367432},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.996999979019165},{"id":"https://openalex.org/keywords/medicare-advantage-enrollees","display_name":"Medicare Advantage enrollees","score":0.9829999804496765},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.6990000009536743},{"id":"https://openalex.org/keywords/community-acquired-infections","display_name":"community-acquired infections","score":0.9789999723434448},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.5609999895095825},{"id":"https://openalex.org/keywords/mortality-risk","display_name":"mortality risk","score":0.3370000123977661},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9368984699249268},{"id":"https://openalex.org/C2910067853","wikidata":"https://www.wikidata.org/wiki/Q27438828","display_name":"Clostridioides","level":2,"score":0.7248327732086182},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.6261453628540039},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.609893798828125},{"id":"https://openalex.org/C45827449","wikidata":"https://www.wikidata.org/wiki/Q5270338","display_name":"Diagnosis code","level":3,"score":0.5361217260360718},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5003247261047363},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.48582884669303894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47888273000717163},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4399501383304596},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4375340938568115},{"id":"https://openalex.org/C2778829437","wikidata":"https://www.wikidata.org/wiki/Q6806632","display_name":"Medicare Advantage","level":3,"score":0.423861563205719},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40493112802505493},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofab466.016","doi":"https://doi.org/10.1093/ofid/ofab466.016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.016","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8644892","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8644892/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8644892/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofab466.016","doi":"https://doi.org/10.1093/ofid/ofab466.016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.016","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200260910.pdf","grobid_xml":"https://content.openalex.org/works/W4200260910.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281737459","https://openalex.org/W4200047341","https://openalex.org/W4405262516","https://openalex.org/W2515633338","https://openalex.org/W4311525766","https://openalex.org/W4311737816","https://openalex.org/W4220941356","https://openalex.org/W2593931864","https://openalex.org/W2982146221","https://openalex.org/W4404538799"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"US":[2],"attributable":[3,181],"CDI":[4,69,73,86,149,318,331],"mortality":[5,92,182,196,323],"and":[6,93,96,113,137,305,314,324,327,338,344],"cost":[7,235,272,287],"data":[8],"are":[9],"primarily":[10],"from":[11,156],"Medicare":[12,19,29],"fee-for-service":[13],"populations.":[14],"Little":[15],"is":[16,319],"known":[17],"about":[18,25],"Advantage":[20],"Enrollees":[21],"(MAEs),":[22],"who":[23,61],"comprise":[24],"39%":[26],"of":[27,59,82,119,124,175,236],"the":[28,117,125,161,177,186,239,279,333],"population.":[30],"Methods":[31],"Using":[32,153],"2017\u20122019":[33],"Optum\u2019s":[34],"de-identified":[35],"Clinformatics\u00ae":[36],"Data":[37],"Mart":[38],"database,":[39],"this":[40],"retrospective":[41],"cohort":[42,192],"study":[43],"identified":[44],"first":[45],"C":[46],"difficile":[47],"infection":[48,135],"(CDI)":[49],"episodes":[50],"occurring":[51],"in":[52,151,160,179,185,290,332],"2018":[53],"among":[54,199,251],"eligible":[55,143],"MAEs":[56],"\u226566":[57],"y":[58],"age":[60],"were":[62,103,114,132,167,224,249],"continuously":[63],"enrolled":[64],"for":[65,204,209,226,260,275,341],"12":[66,126,173],"mo":[67,127,174,281],"before":[68],"diagnosis":[70,78],"(baseline":[71],"period).":[72],"was":[74,183,197,273,288],"defined":[75],"via":[76],"ICD10":[77],"codes":[79],"or":[80,122,385],"evidence":[81],"toxin":[83],"testing":[84],"with":[85,231,321],"antibiotic":[87],"treatment.":[88],"To":[89],"assess":[90],"all-cause":[91],"CDI-associated":[94,268],"healthcare":[95,205,222,247,326,342],"patient":[97],"out-of-pocket":[98],"(OOP)":[99],"costs,":[100],"CDI+":[101,165,187,201,215,227,253,262,276,293,299,303,309],"cases":[102,166,202,216,277,304,310],"matched":[104,168],"1:1":[105],"to":[106,169],"CDI\u2013":[107,170,190,229],"controls":[108],"using":[109],"propensity":[110],"scores":[111],"(PS)":[112],"followed":[115,295],"through":[116],"earliest":[118],"death,":[120],"disenrollment":[121],"end":[123],"followup.":[128,282],"Additionally,":[129],"outcome":[130],"analyses":[131],"stratified":[133],"by":[134,296],"acquisition":[136],"hospitalization":[138],"status.":[139],"Results":[140],"Among":[141],"3,450,354":[142],"MAEs,":[144],"15,195":[145],"(0.4%)":[146],"had":[147],"a":[148],"episode":[150],"2018.":[152],"PS":[154],"generated":[155],">60":[157],"variables":[158],"collected":[159],"baseline":[162],"period,":[163],"14,928":[164],"controls.":[171],"Over":[172],"follow-up,":[176],"difference":[178],"1-y":[180],"7.9%":[184],"(26.3%)":[188],"vs":[189,213,228],"(18.4%)":[191],"(Figure":[193,242],"1).":[194],"CDI-attributable":[195],"higher":[198,225],"hospitalized":[200,252,292,298],"(18.4%":[203],"associated":[206,211,320],"[HA];":[207],"13.1%":[208],"community":[210],"[CA])":[212],"nonhospitalized":[214,261,302,308],"(HA,":[217,255,264],"4.5%;":[218],"CA,":[219,257,266],"1.0%).":[220],"Similarly,":[221],"costs":[223,248,340],"patients,":[230],"excess":[232,245,269,284],"mean":[233,246,270,285],"total":[234,325],"&13,363":[237],"at":[238,278],"2-mo":[240],"follow-up":[241],"2).":[243],"Total":[244,283],"greater":[250],"patients":[254,263],"&28,139;":[256],"&28,136)":[258],"than":[259],"&5741;":[265],"&2503).":[267],"OOP":[271,286,328],"&409":[274],"2":[280],"highest":[289],"CA":[291,307],"cases,":[294,300],"HA":[297,301],"finally":[306],"(&964,":[311],"&574,":[312],"&231":[313],"&197,":[315],"respectively).":[316],"Conclusion":[317],"major":[322],"costs.":[329],"Preventing":[330],"elderly":[334],"may":[335],"improve":[336],"outcomes":[337],"reduce":[339],"systems":[343],"patients.":[345],"Disclosures":[346],"Holly":[347],"Yu,":[348],"MSPH,":[349],"Pfizer":[350,359,365,372,381],"Inc":[351,373],"(Employee,":[352,374],"Shareholder)":[353,375],"Jennifer":[354],"L":[355],"Nguyen,":[356],"ScD,":[357],"MPH,":[358,380],"Inc.":[360,366],"(Employee)":[361,367],"Tamuno":[362],"Alfred,":[363],"PhD,":[364,379],"Jingying":[368],"Zhou,":[369],"MA,":[370],"MEd,":[371],"Margaret":[376],"A.":[377],"Olsen,":[378],"(Consultant,":[382],"Research":[383],"Grant":[384],"Support)":[386]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200260910","counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-12-31T00:00:00"}
